---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039043"
form_type: "8-K"
ticker: "GBCS"
cik: "0000727346"
company_name: "SELECTIS HEALTH, INC."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-31T00:07:46.440075+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Selectis Health raises CEO salary to $250K; CEO waives $30K board stipend

## Summary
- CEO Adam Desmond's salary increased from $150,000 to $250,000 per annum, effective October 1, 2024.
- Desmond agreed to forgo the $7,500 quarterly Board compensation stipend ($30,000/year).
- Net annual increase in cash compensation is approximately $70,000 before other benefits.
- Salary adjustment approved by the Board of Directors on October 1, 2024.

## SEC filing metadata
- accession: 0001493152-24-039043
- form_type: 8-K
- ticker: GBCS
- cik: 0000727346
- company_name: SELECTIS HEALTH, INC.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727346/000149315224039043/0001493152-24-039043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727346/000149315224039043/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039043
- JSON: https://secwatch.observer/filing/0001493152-24-039043.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.